498 related articles for article (PubMed ID: 35536759)
1. MicroRNAs in oligodendrocyte development and remyelination.
Ngo C; Kothary R
J Neurochem; 2022 Aug; 162(4):310-321. PubMed ID: 35536759
[TBL] [Abstract][Full Text] [Related]
2. p38γ MAPK delays myelination and remyelination and is abundant in multiple sclerosis lesions.
Marziali LN; Hwang Y; Palmisano M; Cuenda A; Sim FJ; Gonzalez A; Volsko C; Dutta R; Trapp BD; Wrabetz L; Feltri ML
Brain; 2024 May; 147(5):1871-1886. PubMed ID: 38128553
[TBL] [Abstract][Full Text] [Related]
3. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
Skaper SD
Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination.
Gorter RP; Baron W
Neurosci Lett; 2020 Jun; 729():134980. PubMed ID: 32315713
[TBL] [Abstract][Full Text] [Related]
5. Oligodendrocytes in Development, Myelin Generation and Beyond.
Kuhn S; Gritti L; Crooks D; Dombrowski Y
Cells; 2019 Nov; 8(11):. PubMed ID: 31726662
[TBL] [Abstract][Full Text] [Related]
6. Engineering biomaterial microenvironments to promote myelination in the central nervous system.
Unal DB; Caliari SR; Lampe KJ
Brain Res Bull; 2019 Oct; 152():159-174. PubMed ID: 31306690
[TBL] [Abstract][Full Text] [Related]
7. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
8. The orphan G protein-coupled receptor GPR149 is a negative regulator of myelination and remyelination.
Suo N; He B; Cui S; Yang Y; Wang M; Yuan Q; Xie X
Glia; 2022 Oct; 70(10):1992-2008. PubMed ID: 35758525
[TBL] [Abstract][Full Text] [Related]
9. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
Tepavčević V; Lubetzki C
Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
[TBL] [Abstract][Full Text] [Related]
10. Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis.
Marro BS; Skinner DD; Cheng Y; Grist JJ; Dickey LL; Eckman E; Stone C; Liu L; Ransohoff RM; Lane TE
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243125
[TBL] [Abstract][Full Text] [Related]
11. Schwann cell remyelination of the central nervous system: why does it happen and what are the benefits?
Chen CZ; Neumann B; Förster S; Franklin RJM
Open Biol; 2021 Jan; 11(1):200352. PubMed ID: 33497588
[TBL] [Abstract][Full Text] [Related]
12. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
13. PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination.
Wang Y; Zhang Y; Zhang S; Kim B; Hull VL; Xu J; Prabhu P; Gregory M; Martinez-Cerdeno V; Zhan X; Deng W; Guo F
Cell Rep; 2021 Oct; 37(1):109695. PubMed ID: 34610310
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells.
Zveik O; Fainstein N; Rechtman A; Haham N; Ganz T; Lavon I; Brill L; Vaknin-Dembinsky A
Glia; 2022 Jun; 70(6):1191-1209. PubMed ID: 35266197
[TBL] [Abstract][Full Text] [Related]
15. Myt1L Promotes Differentiation of Oligodendrocyte Precursor Cells and is Necessary for Remyelination After Lysolecithin-Induced Demyelination.
Shi Y; Shao Q; Li Z; Gonzalez GA; Lu F; Wang D; Pu Y; Huang A; Zhao C; He C; Cao L
Neurosci Bull; 2018 Apr; 34(2):247-260. PubMed ID: 29397565
[TBL] [Abstract][Full Text] [Related]
16. The fatty acid binding protein FABP7 is required for optimal oligodendrocyte differentiation during myelination but not during remyelination.
Foerster S; Guzman de la Fuente A; Kagawa Y; Bartels T; Owada Y; Franklin RJM
Glia; 2020 Jul; 68(7):1410-1420. PubMed ID: 32017258
[TBL] [Abstract][Full Text] [Related]
17. Mechanical regulation of oligodendrocyte biology.
Makhija EP; Espinosa-Hoyos D; Jagielska A; Van Vliet KJ
Neurosci Lett; 2020 Jan; 717():134673. PubMed ID: 31838017
[TBL] [Abstract][Full Text] [Related]
18. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
19. Neuronal activity and NIBS in developmental myelination and remyelination - Current state of knowledge.
Scheinok TJ; D'Haeseleer M; Nagels G; De Bundel D; Van Schependom J
Prog Neurobiol; 2023 Jul; 226():102459. PubMed ID: 37127087
[TBL] [Abstract][Full Text] [Related]
20. A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination.
Su W; Matsumoto S; Banine F; Srivastava T; Dean J; Foster S; Pham P; Hammond B; Peters A; Girish KS; Rangappa KS; Basappa ; Jose J; Hennebold JD; Murphy MJ; Bennett-Toomey J; Back SA; Sherman LS
Glia; 2020 Feb; 68(2):263-279. PubMed ID: 31490574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
